The global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market size is predicted to grow from US$ 293 million in 2025 to US$ 1079 million in 2031; it is expected to grow at a CAGR of 24.2% from 2025 to 2031.

Cryoablation refers to a method of freezing diseased tissue through low-temperature technology to achieve in situ inactivation of solid tissue. The working principle is to use low temperature to quickly cool down the diseased tissue to destroy cells, causing cell necrosis or apoptosis, thereby achieving the purpose of treatment. Since cryoablation uses the physical method of energy exchange to achieve the purpose of treatment, its trauma and side effects to the human body are much lower than conventional radiotherapy and chemotherapy, so it is hailed as a "green therapy".
In the 1990s, Endocare, an American company, developed a new type of cryotherapy equipment using the Joule-Thomson throttling refrigeration principle. The equipment uses argon throttling refrigeration and helium throttling heating rewarming to achieve rapid freezing treatment and rewarming needle removal. It is used for ablation treatment of various solid tumors such as lung cancer and liver cancer. China has become the most active country in the world in clinical research on cryoablation tumors.

United States market for Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device players cover Boston Scientific, Metrum Cryoflex, Siemens, AccuTarget MediPharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device Industry Forecast” looks at past sales and reviews total world Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device sales for 2025 through 2031. With Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device industry.

This Insight Report provides a comprehensive analysis of the global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Liquid Nitrogen
    Argon and Helium
    Carbon Dioxide and Nitrous Oxide
    Others

Segmentation by Application:

    Tumor Treatment
    Heart Treatment
    Others

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Boston Scientific
    Metrum Cryoflex
    Siemens
    AccuTarget MediPharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market?
What factors are driving Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market opportunities vary by end market size?
How does Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device break out by Type, by Application?